Bio-Medical Applications Of Pennsylvania, Inc. in Enola, Pennsylvania - Dialysis Center

Bio-Medical Applications Of Pennsylvania, Inc. is a medicare approved dialysis facility center in Enola, Pennsylvania and it has 0 dialysis stations. It is located in Cumberland county at 390 East Penn Drive, Enola, PA, 17025. You can reach out to the office of Bio-Medical Applications Of Pennsylvania, Inc. at (717) 732-3274. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Pennsylvania, Inc. has the following ownership type - Profit. It was first certified by medicare in October, 2016. The medicare id for this facility is 392850 and it accepts patients under medicare ESRD program.

Name	Bio-Medical Applications Of Pennsylvania, Inc.
Location	390 East Penn Drive, Enola, Pennsylvania
No. of Dialysis Stations	0
Medicare ID	392850
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of Pennsylvania, Inc. from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1134589336
Organization Name	Freedom Center Of Central Pennsylvania
Doing Business As	Bio-medical Applications Of Pennsylvania, Inc.
Address	390 E Penn Dr Enola, Pennsylvania, 17025
Phone Number	(717) 732-3274

Dialysis patients with Hemoglobin data

10

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	1
  Adult patient months included in Kt/V greater than or equal to 1.2	2
  Percentage of adult patients getting regular hemodialysis at the center
  Percentage of pediatric patients getting regular hemodialysis at the center

• Peritoneal Dialysis

  Adult patients getting regular peritoneal dialysis at the center	25
  Adult patient months included in Kt/V greater than or equal to 1.7	212
  Percentage of adult patients getting regular peritoneal dialysis at the center	92
  Percentage of pediatric patients getting regular peritoneal dialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of Pennsylvania, Inc. with elevated calcium levels.

Patients with hypercalcemia	26
Hypercalcemia patient months	214
Hypercalcemia patients with serumcalcium greater than 10.2 mg	1
Patients with Serumphosphor	26
Patients with Serumphosphor less than 3.5 mg/dL	7
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	27
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	26
Patients with Serumphosphor from 5.6 to 7 mg/dL	29
Patients with Serumphosphor greater than 7 mg/dL	11

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	1
Patient months included in arterial venous fistula and catheter summaries	3
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer